Bloomberg One of China’s largest listed drug makers said related parties used the firm’s funds to trade its shares, a day after the securities regulator alleged financial data had been fabricated. Kangmei Pharmaceutical Co transferred $1.3 billion to connected entities to trade its own shares, it said in a filing that appeared on the Shanghai exchange. The management of its ...

Bloomberg Nissan Motor Co’s credit standing took another hit, as S&P Global Ratings placed the automaker’s rating on negative watch after it issued a weaker profit outlook last week. There is a more than one-in-three chance of a further delay in Nissan’s profit recovery, said the rating agency, which in February lowered the company’s long-term issuer credit rating for the ...

Bloomberg Liu Shiyu, the former head of China’s securities regulator, is under investigation for suspected law violations and has turned himself in, authorities said. Liu, who remains a senior Communist Party official, is cooperating with the probe, according to a statement from China’s Central Commission for Discipline Inspection. He was chairman of the China Securities Regulatory Commission for three years ...